Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Mitsubishi Tanabe Pharma

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Mitsubishi Tanabe Pharma's 2012 Japan sales performance.

Mitsubishi Tanabe Pharma Corporation

GSK files anaemia drug daprodustat in Japan, its first market

GSK files anaemia drug daprodustat in Japan, its first market

class called vadadustat in late-stage clinical testing that is licensed to Mitsubishi Tanabe Pharma in some Asian markets including Japan.

Voice biomarker device could diagnose depression, heart disease

Voice biomarker device could diagnose depression, heart disease The financing round was led by M Ventures (the corporate venture capital arm of Merck KGaA, Darmstadt, Germany), with MP Healthcare Venture Management (the corporate venture capital arm of Mitsubishi Tanabe

Biogen picks up another drug from wide-ranging Ionis alliance

Biogen picks up another drug from wide-ranging Ionis alliance It was joined last year by Mitsubishi Tanabe Pharma’s Radicava/Radicut (edaravone) last year, which provides another options, but there is still a desperate need for additional therapies.

Mitsubishi buys Israel's NeuroDerm for $1.1bn

Mitsubishi buys Israel's NeuroDerm for $1.1bn Japan's Mitsubishi Tanabe Pharma has boosted its pipeline with a $1.1bn deal to buy NeuroDerm, an Israeli developer of central nervous system therapies. ... Adding ND0612 into the portfolio will help Mitsubishi meet its target of driving US sales to 80bn

Deal Watch - May 2017

Deal Watch - May 2017 It is not known why in December 2015 the territorial rights granted to Mitsubishi for vadadustat for treatment of anaemia, were limited to Japan, SE Asia and India.  From a

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics